The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2a study of once daily oral BAL101553, a novel tumor checkpoint controller (TCC), in adult patients with advanced solid tumors.
 
Juanita Suzanne Lopez
No Relationships to Disclose
 
Elizabeth Ruth Plummer
Honoraria - Bristol-Myers Squibb; Pfizer (I); Roche/Genentech
Consulting or Advisory Role - Astex Pharmaceuticals; Bayer; Clovis Oncology; Modulatex; MSD Oncology; Novartis; Octimet; Pierre Fabre; Roche/Genentech; Vertex
Speakers' Bureau - Novartis
Research Funding - AstraZeneca/MedImmune (Inst)
Patents, Royalties, Other Intellectual Property - Named on patent of use of PARP inhibitor rucaparib (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology
 
Michael-John Devlin
No Relationships to Disclose
 
Robert Rulach
No Relationships to Disclose
 
Alvaro Henrique Ingles Garces
No Relationships to Disclose
 
Noor R Md Haris
No Relationships to Disclose
 
Rowan Miller
Consulting or Advisory Role - Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Donna Crawford
No Relationships to Disclose
 
Manolo D'Arcangelo
No Relationships to Disclose
 
Caterina Aversa
No Relationships to Disclose
 
Alison L. Hannah
Leadership - NeoGenomics Laboratories
Stock and Other Ownership Interests - NeoGenomics Laboratories
Consulting or Advisory Role - Basilea; Jazz Pharmaceuticals; Medivation; Nektar
 
Stephanie Anderson
Employment - Basilea
 
Marc Frederick Engelhardt
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
Thomas Kaindl
Employment - Basilea; Novartis (I)
Stock and Other Ownership Interests - Basilea
 
Patrice Larger
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
Felix Bachmann
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
Heidi A Lane
Employment - Basilea
Stock and Other Ownership Interests - Basilea
Research Funding - Basilea
Patents, Royalties, Other Intellectual Property - Basilea
 
Phil McKernan
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
T.R. Jeffry Evans
Honoraria - Bristol-Myers Squibb; Eisai
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Eisai; Karus Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Eisai
Research Funding - AstraZeneca (Inst); Celgene (Inst); Eisai (Inst); GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Rebecca Sophie Kristeleit
Honoraria - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Consulting or Advisory Role - Basilea; Cerulean Pharma; Clovis Oncology; Roche/Genentech; Sotio
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; Valirx